Page 6 - Buzzing Stocks

FMCG index hits 52-week low; Patanjali, Godrej Cons, HUL, ITC down up to 3%

Thus far in the calendar year 2026, the BSE FMCG index has underperformed the market by falling 7 per cent, as against 4.8 per cent decline in the BSE Sensex.

Shilchar Technologies jumps 10% after posting Q3 results; PAT up 22% YoY

In Q3, Shilchar Technologies posted consolidated net profit of ₹42.34 crore, as compared to ₹34.77 crore year-on-year (Y-o-Y), up 22 per cent.

ITC, Godfrey Phillips, VST Ind slip up to 6% in 2 days on new cigarette tax

In two sessions, ITC shares declined over 5 per cent, Godfrey Phillips over 6 per cent and VST Industries over 3 per cent

Tata Motors PV rises 3% on Jan sales nos; intl biz sales jumps 251% YoY

Tata Motors PV reported total sales of 71,066 units in January 2026, up 47.1 per cent from 48,316 units in January 2025, according to the exchange filing

Latent View Analytics rallies 8%, trades higher for 3rd day; here's why

The Data & Analytics industry is positioned for continued robust growth, driven by organizations' increasing recognition of data as a critical competitive advantage.

E2E Networks, Anant Raj surge up to 10% on tax holiday for cloud services

In comparison, the benchmark NSE Nifty50 was trading almost flat at 24,832.95 levels.

Brokerages raise target price on Nestle as Q3 results beat expectations

Nestle reported an 18.6 per cent growth in consolidated net sales to ₹5,667 crore from ₹4,780 crore in the year-ago period

Dividend stocks: Cochin Shipyard, 4 others to remain in spotlight today

Dividend stocks today, Feb 2: Here is the complete list of stocks that will remain in focus during today's trading session following their decision to reward their shareholders with dividend payouts

Stocks to Watch today: Hyundai Motor India, BSE, ITC, HDFC Bank, MOIL, REC

Stocks to Watch today, February 2, 2026: Here are some of the top stocks to remain in focus today as the markets open after the presentation of Budget 2026

Max Healthcare, Aster DM Healthcare shares outperform post Union Budget

Max Healthcare Institute, Aster DM Healthcare, and Apollo Hospitals Enterprises shares managed to end higher post Union Budget on Sunday amid weakness in markets

PSU banks reel after Budget 2026; shares fall up to 7%: Here's why

All the PSU Bank index constituents were trading lower, with Bank of India, Bank Maharashtra, Indian Bank, Bank of Baroda, and Union Bank of India falling in the range of 3 to 7 per cent

ITC, SBI Card, IEX: 20 of BSE 500 stocks hit 52-week lows post Budget 2026

ACC, IRCTC, IREDA, Akzo Nobel India, Emami, KPIT Technologies and Premier Energies also hit 52-week lows in the intraday trade on February 1

MCX shares tank 15% in trade; here's why investors are dumping the stock

In past one year, MCX shares have rallied 101 per cent, as compared to Sensex's fall of 3.4 per cent

Apex Frozen, Waterbase, Zeal Aqua rise up to 8% post Budget presentation

As per the Budget document, the government proposes to increase the limit for duty-free imports of specified inputs used for processing seafood products for export, to 3 per cent

BSE, Angel One slide upto 6% as tax worries hit stocks ahead of Budget 2026

BSE share price logged the most losses among peers. The stock declined as much as 5.68 per cent

Meesho shares hit 5% lower circuit as Q3 net loss widens 12x YoY to ₹491 cr

Meesho reported a 12 times year-on-year increase in its net loss to ₹490.7 crore compared to ₹37.4 crore in the year-ago period

Muthoot, Manappuram Finance crack up to 8% amid Gold price slide

Shares of gold-loan financers' wilted under selling pressure in Sunday's Budget day special trading session as Gold, Silver prices retreated sharply from record high levels.

Syrma SGS Technology share price jumps over 10% as Q3 net profit doubles

The scrip jumped 10.76 per cent to the day's high of ₹802 on the National Stock Exchange

Cupid shares surge 13% on strongest-ever quarterly results, bonus issue

The stock jumped 13.3 per cent to ₹442 apiece on the National Stock Exchange (NSE)

Strides Pharma jumps 12% on healthy Q3 operational performance

The management said Strides continues to deliver a strong performance in Q3FY26 with growth primarily driven by the Other Regulated Markets and Growth Markets.